SEC Form 4 · accession 0002065630-26-000006
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian J Donnelly
Officer — Chief Commerical Officer
Period of report
Jun 11, 2026
Accepted (ET)
Jun 12, 2026 · 6:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 11, 2026 | A | 5,000 | $3.936 | A | 573,363 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Issuer's Amended and Restated 2012 Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).